Ultralife (ULBI) Q2 2026 earnings review
Profitability Surges on Margin Recovery Despite Flat Revenue
Ultralife's Q2 2026 delivered a sharp profitability reversal after a disastrous Q1. While total revenue slightly decelerated by 1.3% YoY to $47.9M, gross margins exploded by 760 basis points sequentially to 28.9%. Even excluding a $1.1M IEEPA tariff refund, baseline gross margin of 26.6% indicates the company is successfully overcoming the manufacturing inefficiencies that plagued the prior quarter. This margin expansion drove GAAP EPS to $0.15 (up 200% YoY) and Adjusted EBITDA to $6.1M. A record $117.5M backlog and a massive rebound in the Communications Systems segment offset lingering weakness in commercial battery markets.
🐂 Bull Case
Gross margin expanded to 28.9% (26.6% ex-refunds), overcoming the severe operational headwinds seen in Q1. Management cited measurable benefits from initiatives addressing manufacturing inefficiencies.
Backlog reached an all-time high of $117.5M. With multi-year revenue opportunities transitioning into production later this year, the pipeline for sustained top-line growth is robust.
🐻 Bear Case
Battery & Energy revenue fell 3.7% YoY. This was driven by a continuing decline in high-margin oil & gas and industrial sales (-8.7% YoY), indicating sluggish macroeconomic demand.
Operating expenses jumped to 21.8% of revenue. The company logged another $0.9M in non-recurring costs (consulting, cyber-litigation). These 'one-time' adjustments have appeared consistently for several quarters, muddying true operational leverage.
⚖️ Verdict: 🟢
Bullish. The Q2 results confirm that Q1's operational failures (power outages, ERP shutdowns) were temporary. The successful turnaround of margins, combined with a surging backlog and Communications Systems recovery, heavily outweighs softness in commercial battery markets.
Key Themes
Communications Systems Reverses Course
After a grueling Q1 where segment revenue plummeted 25.7% YoY, Communications Systems staged a dramatic reversal. Q2 revenue surged 39.3% YoY to $3.8M. Gross margins in this segment expanded sharply from 28.4% to 36.3% due to a highly favorable sales mix. Management notes the segment is poised for further gains as multiple new products transition into production for government/defense programs.
Unprecedented Backlog Accumulation
The company’s backlog continues an accelerating upward trend, hitting a record $117.5M (up from $115.1M in Q1 2026 and $84.5M a year ago). This swelling order book, bolstered by new product developments transitioning into the capture phase, provides massive visibility into late 2026 and 2027 revenue streams.
Weakness in Core Commercial Battery Markets
Despite the total company profitability turnaround, the Battery & Energy Products segment remains challenged on the top line. Commercial sales dropped 4.7% YoY, heavily impacted by an 8.7% decline in oil & gas and industrial sales. While medical battery sales grew 7.2%, they were insufficient to offset the industrial drag, underscoring ongoing macroeconomic sensitivity.
Tax Credits Offset Debt Burden
Other expense dropped significantly YoY (from $1.1M to $0.5M). While interest expense remains elevated due to the Electrochem acquisition debt, the company successfully offset this using the 45X Advanced Manufacturing Production Tax Credit (Inflation Reduction Act) for its manufactured battery cells and packs. This credit represents an ongoing structural tailwind to net income.
Elevated and Persistent OpEx Adjustments
Operating expenses rose to 21.8% of revenue from 19.2% a year ago. A major component is a recurring wave of 'one-time' expenses, which hit $0.9M this quarter (up from $0.3M in 25Q2). Management cites cyber-insurance litigation and consultants hired to 'expedite gross margin improvement.' Investors must question when these recurring adjustments will normalize.
Other KPIs
Accelerating significantly. Up 50% YoY from $4.1M in the prior-year quarter, and a near-doubling from the weak $3.2M posted in Q1 2026. This translates to an impressive 12.8% EBITDA margin, compared to 8.5% YoY, driven entirely by gross margin recovery.
A massive recovery. Up from $0.05 a year ago and rebounding from a net loss of $0.03 per share in Q1 2026. The IEEPA tariff refund drove roughly 35-40% of this beat, but core operational improvement provided the majority of the uplift.
Guidance
Stable outlook. Management did not provide hard quantitative guidance but reinforced their expectation for profitable growth in 2026. They explicitly tied this confidence to multi-year revenue opportunities from the $117.5M backlog and the success of gross margin improvement initiatives.
Key Questions
Timing of Backlog Conversion
With the backlog reaching an all-time high of $117.5M, what percentage of this is expected to convert to revenue in the second half of 2026 versus 2027?
OpEx Normalization
The company recorded $0.9M in one-time costs this quarter, following $0.8M last quarter. When can investors expect these consulting and litigation fees to fully roll off the income statement?
Commercial Market Outlook
Oil and gas and industrial sales declined 8.7% in Q2. Are you seeing any stabilization in these end-markets, or should we expect continued softness through the end of the year?
Margin Sustainability
Excluding the IEEPA refund, gross margin was 26.6%. Given the favorable sales mix in Communications Systems this quarter, is 26-27% the right run-rate expectation going forward, or are further efficiencies expected?